
Roy P. Rabindranath
Examiner (ID: 18614, Phone: (571)270-5722 , Office: P/2691 )
| Most Active Art Unit | 2691 |
| Art Unit(s) | 2618, 2621, 2691, 2623, 2629 |
| Total Applications | 719 |
| Issued Applications | 597 |
| Pending Applications | 35 |
| Abandoned Applications | 106 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17334614
[patent_doc_number] => 20220000945
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => METHODS FOR COLONIZING WITH BENEFICIAL ORAL BACTERIA
[patent_app_type] => utility
[patent_app_number] => 17/477380
[patent_app_country] => US
[patent_app_date] => 2021-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8552
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17477380
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/477380 | Methods for colonizing with beneficial oral bacteria | Sep 15, 2021 | Issued |
Array
(
[id] => 17783570
[patent_doc_number] => 11406675
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-09
[patent_title] => Therapeutic pharmaceutical compositions
[patent_app_type] => utility
[patent_app_number] => 17/475228
[patent_app_country] => US
[patent_app_date] => 2021-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 36
[patent_no_of_words] => 34074
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17475228
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/475228 | Therapeutic pharmaceutical compositions | Sep 13, 2021 | Issued |
Array
(
[id] => 17312703
[patent_doc_number] => 20210401751
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => COMPOSITIONS FOR TREATING VIRAL INFECTIONS AND METHODS FOR SAME
[patent_app_type] => utility
[patent_app_number] => 17/472750
[patent_app_country] => US
[patent_app_date] => 2021-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8359
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17472750
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/472750 | Compositions for treating viral infections and methods for same | Sep 12, 2021 | Issued |
Array
(
[id] => 17312915
[patent_doc_number] => 20210401963
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => MULTIVALENT PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE COMPOSTION
[patent_app_type] => utility
[patent_app_number] => 17/471825
[patent_app_country] => US
[patent_app_date] => 2021-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17184
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17471825
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/471825 | Multivalent pneumococcal polysaccharide-protein conjugate composition | Sep 9, 2021 | Issued |
Array
(
[id] => 17441895
[patent_doc_number] => 20220062400
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => Injectable Botulinum Toxin Formulations And Methods Of Use Thereof Having Long Duration Of Therapeutic Or Cosmetic Effect
[patent_app_type] => utility
[patent_app_number] => 17/472525
[patent_app_country] => US
[patent_app_date] => 2021-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22291
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17472525
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/472525 | Injectable Botulinum Toxin Formulations And Methods Of Use Thereof Having Long Duration Of Therapeutic Or Cosmetic Effect | Sep 9, 2021 | Pending |
Array
(
[id] => 17315971
[patent_doc_number] => 20210405019
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => OBTAINING INFORMATION FROM A BIOLOGICAL SAMPLE IN A FLOW CELL
[patent_app_type] => utility
[patent_app_number] => 17/470228
[patent_app_country] => US
[patent_app_date] => 2021-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22374
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17470228
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/470228 | Obtaining information from a biological sample in a flow cell | Sep 8, 2021 | Issued |
Array
(
[id] => 17297925
[patent_doc_number] => 20210393764
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => Immunogenic Compositions for Use in Pneumococcal Vaccines
[patent_app_type] => utility
[patent_app_number] => 17/463691
[patent_app_country] => US
[patent_app_date] => 2021-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29720
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17463691
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/463691 | Immunogenic Compositions for Use in Pneumococcal Vaccines | Aug 31, 2021 | Abandoned |
Array
(
[id] => 17299475
[patent_doc_number] => 20210395314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => MODIFIED BACTERIAL MICROCOMPARTMENT SHELL PROTEIN
[patent_app_type] => utility
[patent_app_number] => 17/458131
[patent_app_country] => US
[patent_app_date] => 2021-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14814
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17458131
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/458131 | Modified bacterial microcompartment shell protein | Aug 25, 2021 | Issued |
Array
(
[id] => 18691024
[patent_doc_number] => 20230321212
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => GROUP B STREPTOCOCCUS POLYSACCHARIDE-PROTEIN CONJUGATES, METHODS FOR PRODUCING CONJUGATES, IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATES, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/042561
[patent_app_country] => US
[patent_app_date] => 2021-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41465
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18042561
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/042561 | GROUP B STREPTOCOCCUS POLYSACCHARIDE-PROTEIN CONJUGATES, METHODS FOR PRODUCING CONJUGATES, IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATES, AND USES THEREOF | Aug 22, 2021 | Pending |
Array
(
[id] => 17297922
[patent_doc_number] => 20210393761
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => ISOLATED POLYPEPTIDE OF THE TOXIN A AND TOXIN B PROTEINS OF C. DIFFICILE AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/406765
[patent_app_country] => US
[patent_app_date] => 2021-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30479
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17406765
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/406765 | Isolated polypeptide of the toxin A and toxin B proteins of | Aug 18, 2021 | Issued |
Array
(
[id] => 20378984
[patent_doc_number] => 20250361477
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-11-27
[patent_title] => PRODUCTION OF AN OLIGOSACCHARIDE MIXTURE BY A CELL
[patent_app_type] => utility
[patent_app_number] => 18/040378
[patent_app_country] => US
[patent_app_date] => 2021-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 81612
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18040378
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/040378 | PRODUCTION OF AN OLIGOSACCHARIDE MIXTURE BY A CELL | Aug 9, 2021 | Pending |
Array
(
[id] => 18801325
[patent_doc_number] => 11834477
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-05
[patent_title] => Method for the acute treatment of atopic dermatitis and allergic skin hypersensitivity
[patent_app_type] => utility
[patent_app_number] => 17/397816
[patent_app_country] => US
[patent_app_date] => 2021-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 11
[patent_no_of_words] => 9115
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17397816
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/397816 | Method for the acute treatment of atopic dermatitis and allergic skin hypersensitivity | Aug 8, 2021 | Issued |
Array
(
[id] => 17244772
[patent_doc_number] => 20210364515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => OPTIMIZING DIAGNOSTICS FOR GALACTOFURANOSE CONTAINING ANTIGENS
[patent_app_type] => utility
[patent_app_number] => 17/388733
[patent_app_country] => US
[patent_app_date] => 2021-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11667
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17388733
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/388733 | OPTIMIZING DIAGNOSTICS FOR GALACTOFURANOSE CONTAINING ANTIGENS | Jul 28, 2021 | Abandoned |
Array
(
[id] => 18444722
[patent_doc_number] => 11680282
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-20
[patent_title] => Apparatus and method for distinguishing antibiotics susceptibility
[patent_app_type] => utility
[patent_app_number] => 17/386687
[patent_app_country] => US
[patent_app_date] => 2021-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 5502
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17386687
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/386687 | Apparatus and method for distinguishing antibiotics susceptibility | Jul 27, 2021 | Issued |
Array
(
[id] => 17241983
[patent_doc_number] => 20210361726
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => INHALED RESPIRATORY PROBIOTICS FOR LUNG DISEASES OF INFANCY, CHILDHOOD AND ADULTHOOD
[patent_app_type] => utility
[patent_app_number] => 17/384272
[patent_app_country] => US
[patent_app_date] => 2021-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15940
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17384272
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/384272 | Inhaled respiratory probiotics for lung diseases of infancy, childhood and adulthood | Jul 22, 2021 | Issued |
Array
(
[id] => 17214495
[patent_doc_number] => 20210347832
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => ARTICLES COMPRISING A SILK POLYPEPTIDE FOR ANTIGEN DELIVERY
[patent_app_type] => utility
[patent_app_number] => 17/383926
[patent_app_country] => US
[patent_app_date] => 2021-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22638
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17383926
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/383926 | Articles comprising a silk polypeptide for antigen delivery | Jul 22, 2021 | Issued |
Array
(
[id] => 18852726
[patent_doc_number] => 11850278
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-26
[patent_title] => Compositions comprising
[patent_app_type] => utility
[patent_app_number] => 17/374424
[patent_app_country] => US
[patent_app_date] => 2021-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 62
[patent_no_of_words] => 62150
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17374424
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/374424 | Compositions comprising | Jul 12, 2021 | Issued |
Array
(
[id] => 17577044
[patent_doc_number] => 20220133899
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => PREPARATION OF MAYTANSINOID ANTIBODY CONJUGATES BY A ONE-STEP PROCESS
[patent_app_type] => utility
[patent_app_number] => 17/371151
[patent_app_country] => US
[patent_app_date] => 2021-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17160
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17371151
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/371151 | Preparation of maytansinoid antibody conjugates by a one-step process | Jul 8, 2021 | Issued |
Array
(
[id] => 18673158
[patent_doc_number] => 20230310650
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => Bacterial Vehicle for Engineering of Non-Phagocytic Immune Cells
[patent_app_type] => utility
[patent_app_number] => 18/014649
[patent_app_country] => US
[patent_app_date] => 2021-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28328
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18014649
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/014649 | Bacterial Vehicle for Engineering of Non-Phagocytic Immune Cells | Jul 6, 2021 | Pending |
Array
(
[id] => 17334663
[patent_doc_number] => 20220000994
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => Peptide Conjugated Particles
[patent_app_type] => utility
[patent_app_number] => 17/364351
[patent_app_country] => US
[patent_app_date] => 2021-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34130
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17364351
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/364351 | Peptide conjugated particles | Jun 29, 2021 | Issued |